(Q33510952)

27 July 2017

title

Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. (English)

1 reference

27 July 2017

main subject

hepatocellular carcinoma

1 reference

Jin-Cai Wu

1

1 reference

27 July 2017

Bing-Sheng Sun

2

1 reference

27 July 2017

Ning Ren

3

1 reference

27 July 2017

Qing-Hai Ye

4

1 reference

27 July 2017

Lun-Xiu Qin

5

1 reference

27 July 2017

publication date

16 October 2009

1 reference

Journal of Cancer Research and Clinical Oncology

27 July 2017

published in

1 reference

27 July 2017

volume

136

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

595-601

1 reference

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

27 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0695-0

The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model

21 January 2018

1 reference

12 December 2020

Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line

1 reference

12 December 2020

Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation

1 reference

12 December 2020

Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma

1 reference

12 December 2020

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin

1 reference

12 December 2020

Osteopontin: possible role in prostate cancer progression

1 reference

12 December 2020

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

1 reference

12 December 2020

Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas

1 reference

12 December 2020

The role of osteopontin in tumorigenesis and metastasis.

1 reference

12 December 2020

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

1 reference

12 December 2020

Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.

1 reference

12 December 2020

Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.

1 reference

12 December 2020

PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation

1 reference

12 December 2020

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness

1 reference

12 December 2020

Osteopontin expression and function: role in bone remodeling

1 reference

12 December 2020

Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma

1 reference

12 December 2020

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

1 reference

12 December 2020

Overexpression of osteopontin in hepatocellular carcinoma

1 reference

12 December 2020

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies

1 reference

12 December 2020

Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.

1 reference

12 December 2020

Molecular definition of breast tumor heterogeneity

1 reference

12 December 2020

Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications

1 reference

12 December 2020

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma

1 reference

12 December 2020

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

1 reference

12 December 2020

Osteopontin identified as colon cancer tumor progression marker

1 reference

12 December 2020

Increased expression of osteopontin contributes to the progression of prostate cancer

1 reference

12 December 2020

Ephrin A5 expression promotes invasion and transformation of murine fibroblasts

1 reference

12 December 2020

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

12 December 2020

Role of osteopontin in tumour progression

1 reference

12 December 2020

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

1 reference

12 December 2020

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

1 reference

12 December 2020

Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma.

1 reference

12 December 2020

Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.

1 reference

12 December 2020

10.1007/S00432-009-0695-0

Identifiers

DOI

1 reference

27 July 2017

1 reference